NCT06783140: Study of NABPLAGEM vs. Nab-Paclitaxel/Gemcitabine in BRCA1/2 or PALB2 Pancreatic Cancer
- State
- Under way
- Phase
- Phase 2 and Phase 3
- People
- 10 planned
- Started
- 10 Jun 2025
- Primary completion
- 2 Jun 2031
- Arms
- Arm 1- NABPLAGEM (Nab-paclitaxel+Cisplatin+Gemcitabine)
- Results
- None posted
- 20 Jan 2025: Trial registered
- 10 Jun 2025: Trial started